Código QR (código de barras bidimensional)

Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation

Abstract Because hepatic stellate cells (HSCs) play a major role in fibrosis, we focused on HSCs as a potential target for the treatment of liver fibrosis. In this study, we attempted to identify drug candidates to inactivate HSCs and found that several proteasome inhibitors (PIs) reduced HSC viabil...

Fuld beskrivelse

Na minha lista:
Principais autores: Ayana Fujiwara, Keisuke Takemura, Anna Tanaka, Misaki Matsumoto, Masato Katsuyama, Takeshi Okanoue, Kanji Yamaguchi, Yoshito Itoh, Kazumi Iwata, Kikuko Amagase, Atsushi Umemura
Format: Artigo
Sprog:Inglês
Udgivet: Nature Portfolio 2024-08-01
Serier:Scientific Reports
Fag:
Proteasome inhibitor
Carfilzomib
Hepatic stellate cell
Liver fibrosis
Online adgang:https://doi.org/10.1038/s41598-024-70296-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker